Pembrolizumab plus gemcitabine and cisplatin for advanced biliary tract cancer: longer-term follow-up from the randomised, double-blind, placebo-controlled, phase 3 KEYNOTE-966 trial. [PDF]
Ueno M +21 more
europepmc +1 more source
ABSTRACT Nationwide prospective data on the clinical management of cutaneous angiosarcoma in Japan are lacking. We analyzed 3 years of data from the Japan Skin Cancer Registry Study, a registry involving 86 institutions. Analyses were restricted to the 335 patients registered at least 12 months before the follow‐up data cutoff, a criterion independent ...
Hiroshi Kato +18 more
wiley +1 more source
Toxicity attribution during enfortumab vedotin plus pembrolizumab therapy in urothelial carcinoma: a practical framework. [PDF]
Zarka J +12 more
europepmc +1 more source
ABSTRACT Introduction Transoral robotic surgery (TORS) and radiotherapy are both recognised as effective treatment options for early‐stage HPV‐associated oropharyngeal squamous cell carcinoma (HPV‐OPSCC). TORS offers the benefit of a shorter total treatment duration; however, a proportion of patients require adjuvant radiotherapy with or without ...
Lan Gao +3 more
wiley +1 more source
Neuronal intermediate filament neurologic autoimmunity in a patient with Merkel cell carcinoma receiving pembrolizumab. [PDF]
Hijazi A +4 more
europepmc +1 more source
In advanced rectal cancer patients receiving total neoadjuvant therapy (TNT), overall tumor response did not differ by diabetes status or metformin use. However, among diabetic patients, metformin use was associated with higher overall complete response rates. These findings suggest a potential benefit of metformin in enhancing TNT response in diabetic
Sergei Bedrikovetski +7 more
wiley +1 more source
Small-molecule inhibitors and checkpoint inhibitors in KRAS G12C NSCLC: balancing efficacy and toxicity. [PDF]
Wagener EDA, Noordhof AL, van Geffen WH.
europepmc +1 more source
Benchmarked Colorectal Cancer Outcomes in a Metropolitan Hospital: A 5‐Year Review
In metastatic disease, patients with lung‐only metastasis had the best 5‐year survival at 46.0% and curative‐intent approaches can dramatically improve survival. ABSTRACT Introduction Colorectal cancer (CRC) remains a major contributor to cancer‐related mortality worldwide, with survival influenced by many prognostic factors.
Jialin Du +3 more
wiley +1 more source
Multifocal FDG-avid pancreatic pseudomasses mimicking metastases during pembrolizumab for axillary recurrence of triple-negative breast cancer: a case report of immune-related pancreatitis. [PDF]
Matte P +8 more
europepmc +1 more source
Expanding on the growing evidence for neoadjuvant immunotherapy in resectable non‐small cell lung cancer, this study explored neoadjuvant nivolumab ± denosumab. Two of the 10 treated patients achieved a pathological complete response. CD8 T‐cell infiltration correlated with pathological response, warranting ongoing translational research to understand ...
Elizabeth Ahern +11 more
wiley +1 more source

